Evidence map›Paper›PMID 32405973›Full record

ArticleMolecular and cellular biochemistry2020

Identification of Ala2Thr mutation in insulin gene from a Chinese MODY10 family.

Juan Zhang, Yanjun Liu, Ming Li, Xiaoxu Ge, Ying Wang, Xin Huang, Di Yang, Rong Zhang, Yating Chen, Ming Lu and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. A rare homozygousBMJ open diabetes research & care · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Juan ZhangShanghai Diabetes Institute, Department of Endocrinology & Metabolism, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China.
Yanjun LiuDepartment of Internal Medicine, Charles R. Drew University, Los Angeles, USA.
Ming LiShanghai Diabetes Institute, Department of Endocrinology & Metabolism, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China.
Xiaoxu GeDepartment of Endocrinology, School of Medicine, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University, Shanghai, China.
Ying WangDepartment of Pediatrics, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, 90502, USA.
Xin HuangSchool of Medicine, Magee-Womens Research Institute, University of Pittsburgh, 204 Craft Ave., Pittsburgh, PA, 15213, USA.
Di YangDepartment of Nutritional Science and Toxicology, University of California at Berkeley, Berkeley, USA.
Rong ZhangShanghai Diabetes Institute, Department of Endocrinology & Metabolism, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China.
Yating ChenShanghai Diabetes Institute, Department of Endocrinology & Metabolism, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China.
Ming LuDepartment of Endocrinology & Metabolism, Putuo Hospital Attached to Shanghai University of Traditional Chinese Medicine, 164 Lanxi Road, Shanghai, 200000, China.
Jun YinShanghai Diabetes Institute, Department of Endocrinology & Metabolism, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China.
Mingqiang SongDepartment of Endocrinology, Weihai Municipal Hospital, No. 70, Heping Road, Weihai, 264200, China.
Yongfeng WangDepartment of Endocrinology, Xianxian Hospital of Traditional Chinese Medicine, Cangzhou City, Hebei Province, China.
Yanzhong WangSchool of Population Health and Environmental Science, King's College London, London, UK.
Feng WangDepartment of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China.
Meisheng JiangDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
Limei LiuShanghai Diabetes Institute, Department of Endocrinology & Metabolism, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China. lmliu@sjtu.edu.cn.ORCID http://orcid.org/0000-0002-1570-4786
Shanghai Sixth People's Hospital · CNKing's College London · GBUniversity of California, Los Angeles · USShanghai Jiao Tong University · CNShanghai University of Traditional Chinese Medicine · CNUniversity of California, Berkeley · USUniversity of Pittsburgh · USWeihai Municipal Hospital · CN

Funding

The Role of Adipose H6PDH in Type 2 Diabetes and ObesitySC1DK104821 · NIDDK · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI LIU, YANJUN · 2014 to 2017
$1.3M
Interdisciplinary Program of Shanghai Jiao Tong University YG2019ZDA08National Institute of Diabetes and Digestive and Kidney Diseases (US) SC1DK104821National Natural Science Foundation of China 81270876National Natural Science Foundation of China 81471012National Natural Science Foundation of China 81770791National Natural Science Foundation of China 81970686Shanghai Leading Talent SLJ15055
6 · The paper itself

Abstract

More than 80% of maturity-onset diabetes of the young (MODY) in Chinese is genetically unexplained. To investigate whether the insulin gene (INS) mutation is responsible for some Chinese MODY, we screened INS mutations causing MODY10 in MODY pedigrees and explored the potential pathogenic mechanisms. INS mutations were screened in 56 MODY familial probands. Structure-function characterization and clinical profiling of identified INS mutations were conducted. An INS mutation, at the position 2 alanine-to-threonine substitution (A2T), was identified and co-segregated with hyperglycemia in a MODY pedigree. The A2T mutation converted an α-helix into a β-sheet at the N-terminal of the signal peptide (SP) of preproinsulin. The A2T mutation did not affect preproinsulin translocation across endoplasmic reticulum (ER) membrane, but impaired its SP cleavage within the ER. In INS-1 cells transfected with an A2T mutant, glucose-stimulated insulin secretion (GSIS) was significantly decreased, while BiP luciferase activities were significantly increased compared to that of wild type (WT). We identified an INS-A2T mutation cosegregating with diabetes in a Chinese MODY pedigree. This mutation severely impaired SP cleavage and thus blocked the formation of proinsulin, resulting in enhanced ER stress, which may be responsible for decreased insulin secretion and subsequently, the onset of MODY10.

Indexed as

MutationAdultAlanineCell LineChinaDiabetes Mellitus, Type 2Endoplasmic Reticulum StressFamily HealthFemaleGenetic Predisposition to DiseaseGlucoseHumansHyperglycemiaInsulinMaleMiddle AgedAlanineGlucoseInsulinThreonineAla2ThrChineseInsulin geneMODY10Mutation

Identifiers

PMID32405973
OpenAlexW3024690524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.